United States Drug Enforcement Administration

Thanks to community members, community partners, volunteers and members of the Drug Enforcement Administration’s Rocky Mountain Field Division (RMFD) the 26th National Prescription Drug Take Back Day was again a success. This past Saturday, often in challenging weather, people brought in their unneeded, unwanted or expired prescription medications to dozens...

El Paso – Together with its law enforcement partners, the Drug Enforcement Administration will host its 26th National Prescription Drug Take Back Day on Saturday, April 27, from 10 a.m. to 2 p.m. This event aims to remove unneeded prescriptions from homes to help prevent medication misuse by offering anonymous...

The Drug Enforcement Administration’s Rocky Mountain Field Division (RMFD) is proud to be part of the 26th annual National Prescription Drug Take Back Day this Saturday, April 27, 2024 from 10:00am to 2:00pm MST at dozens of locations across Colorado, Utah, Wyoming and Montana. “DEA’s Take Back events serve as...

EDINA, Minn. – The U.S. Attorney’s Office for the District of Minnesota in partnership with the Drug Enforcement Administration Omaha Division hosted a Fentanyl Awareness and Prevention Summit at the Edina Public Library earlier today in an effort to provide education to the community on the potentially lethal consequences of...

NEW HAVEN, Conn. - Vanessa Roberts Avery, United States Attorney for the District of Connecticut, and Stephen Belleau, Acting Special Agent in Charge of the Drug Enforcement Administration for New England, today announced that Cornerstone Pharmacy, Inc. (doing business as “Whalley Drug”), and its owner, YONG KWON, have entered into...

NEWARK, N.J. – A pharmaceutical manufacturer agreed to pay $2.25 million to resolve allegations that it violated the Controlled Substances Act (CSA), DEA New Jersey Field Division Special Agent in Charge Cheryl Ortiz and U.S. Attorney Philip R. Sellinger announced today The manufacturer, Novel Laboratories Inc. (Novel), a subsidiary of...

POCATELLO – Dr. Gerald Knouf, a family medicine doctor formerly of Pocatello, Idaho, agreed to pay $96,000 to resolve allegations that he wrote unlawful prescriptions, prescribed dangerous combinations of drugs, and billed Medicare and Medicaid for services that were not performed, U.S. Attorney Josh Hurwit announced today. The settlement also...

Albuquerque, N.M. – As part of Operation Engage, DEA is hosting its fourth annual Citizen’s Academy this coming May and is now accepting applications. The deadline to submit an application is Tuesday April 30 at 11:59 p.m. The DEA Citizens Academy allows community leaders to gain an understanding of DEA’s...

NEWARK, N.J. – The owner of a New Jersey company today admitted mislabeling hazardous chemicals entering the United States and evading customs duties, DEA New Jersey Field Division Special Agent in Charge Cheryl Ortiz and U.S. Attorney Philip R. Sellinger announced today. George Volpe, 60, of Roseland, New Jersey, owner...

WACO, Texas – Shrieve Chemical Company, LLC, a Drug Enforcement Administration-registered importer and distributor of listed chemicals, has agreed to pay $300,000 in civil penalties to resolve allegations that it violated provisions of the Controlled Substances Act, 21 U.S.C. §§ 801 et seq. In December 2022, DEA diversion investigators conducted...